Free Trial

Promis Neurosciences (PMN) Competitors

Promis Neurosciences logo
$0.44 +0.02 (+5.24%)
Closing price 04:00 PM Eastern
Extended Trading
$0.42 -0.02 (-4.75%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PMN vs. MGNX, SAVA, COYA, IPA, SKYE, IFRX, HLVX, SRZN, ONCY, and EQ

Should you be buying Promis Neurosciences stock or one of its competitors? The main competitors of Promis Neurosciences include MacroGenics (MGNX), Cassava Sciences (SAVA), Coya Therapeutics (COYA), ImmunoPrecise Antibodies (IPA), Skye Bioscience (SKYE), InflaRx (IFRX), HilleVax (HLVX), Surrozen (SRZN), Oncolytics Biotech (ONCY), and Equillium (EQ). These companies are all part of the "pharmaceutical products" industry.

Promis Neurosciences vs. Its Competitors

MacroGenics (NASDAQ:MGNX) and Promis Neurosciences (NASDAQ:PMN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

MacroGenics presently has a consensus price target of $3.60, indicating a potential upside of 126.42%. Promis Neurosciences has a consensus price target of $4.33, indicating a potential upside of 885.07%. Given Promis Neurosciences' stronger consensus rating and higher possible upside, analysts plainly believe Promis Neurosciences is more favorable than MacroGenics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MacroGenics
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.57
Promis Neurosciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Promis Neurosciences has lower revenue, but higher earnings than MacroGenics. MacroGenics is trading at a lower price-to-earnings ratio than Promis Neurosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MacroGenics$163.87M0.61-$66.97M-$0.57-2.79
Promis NeurosciencesN/AN/A$2.78M-$0.21-2.09

In the previous week, MacroGenics and MacroGenics both had 2 articles in the media. MacroGenics' average media sentiment score of 1.53 beat Promis Neurosciences' score of 1.45 indicating that MacroGenics is being referred to more favorably in the media.

Company Overall Sentiment
MacroGenics Very Positive
Promis Neurosciences Positive

MacroGenics has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Comparatively, Promis Neurosciences has a beta of -0.05, suggesting that its share price is 105% less volatile than the S&P 500.

96.9% of MacroGenics shares are owned by institutional investors. Comparatively, 50.1% of Promis Neurosciences shares are owned by institutional investors. 13.0% of MacroGenics shares are owned by insiders. Comparatively, 6.1% of Promis Neurosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Promis Neurosciences has a net margin of 0.00% compared to MacroGenics' net margin of -21.99%. MacroGenics' return on equity of -40.24% beat Promis Neurosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
MacroGenics-21.99% -40.24% -14.62%
Promis Neurosciences N/A -266.69%-131.59%

Summary

MacroGenics beats Promis Neurosciences on 8 of the 15 factors compared between the two stocks.

Get Promis Neurosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PMN vs. The Competition

MetricPromis NeurosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$22.79M$3.13B$5.79B$10.15B
Dividend YieldN/A2.32%5.69%4.60%
P/E Ratio-2.0921.3074.5925.92
Price / SalesN/A257.21453.5485.33
Price / CashN/A45.3337.0859.91
Price / Book0.889.6112.156.29
Net Income$2.78M-$53.29M$3.28B$270.77M
7 Day Performance2.30%0.28%0.99%3.36%
1 Month Performance-37.16%8.91%7.21%6.41%
1 Year Performance-64.81%13.14%63.07%28.24%

Promis Neurosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PMN
Promis Neurosciences
3.6842 of 5 stars
$0.44
+5.2%
$4.33
+885.1%
-66.0%$22.79MN/A-2.095Positive News
Short Interest ↓
MGNX
MacroGenics
4.4794 of 5 stars
$1.74
-1.7%
$3.60
+106.9%
-54.4%$111.87M$149.96M-3.05430Positive News
High Trading Volume
SAVA
Cassava Sciences
2.3318 of 5 stars
$2.27
-0.4%
$2.00
-11.9%
-92.1%$110.14MN/A-0.8930Positive News
COYA
Coya Therapeutics
2.8187 of 5 stars
$6.52
-0.6%
$16.50
+153.1%
+4.2%$109.72M$3.55M-5.266
IPA
ImmunoPrecise Antibodies
2.6324 of 5 stars
$1.93
-18.6%
$4.00
+107.3%
+229.9%$109.39M$17.59M-2.8480Upcoming Earnings
Gap Up
SKYE
Skye Bioscience
2.1118 of 5 stars
$3.38
-3.4%
$15.50
+358.6%
-32.9%$108.46MN/A-3.1911
IFRX
InflaRx
3.2483 of 5 stars
$1.75
+9.4%
$6.20
+254.3%
+2.1%$107.41M$180K-2.1960News Coverage
Positive News
Short Interest ↓
Gap Up
High Trading Volume
HLVX
HilleVax
1.5972 of 5 stars
$2.08
-0.5%
$2.00
-3.8%
+22.2%$104.79MN/A-1.4520Positive News
Short Interest ↑
SRZN
Surrozen
2.9909 of 5 stars
$12.32
+1.1%
$38.50
+212.5%
+36.0%$104.43M$10.65M-0.8580Positive News
ONCY
Oncolytics Biotech
2.4081 of 5 stars
$1.15
+10.6%
$5.00
+334.8%
+38.6%$104.38MN/A-4.2630
EQ
Equillium
0.7692 of 5 stars
$1.72
-1.1%
$1.00
-41.9%
+134.1%$103.54M$41.10M-3.0740Short Interest ↓

Related Companies and Tools


This page (NASDAQ:PMN) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners